A Novel Approach for Determining Cancer Genomic Breakpoints in the Presence of Normal DNA

Yu-Tsueng Liu, Dennis A. Carson · 2007

Read A Novel Approach for Determining Cancer Genomic Breakpoints in the Presence of Normal DNA by Yu-Tsueng Liu, Dennis A. Carson (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000380.txt.

Introduction

Yu-Tsueng Liu and Dennis A. Carson presented a new laboratory approach in PLOS ONE in 2007 for finding breakpoints in cancer genomes. A breakpoint is a spot where a chromosome has broken and rejoined, an error that can drive cancer growth. Tumor samples are usually mixed with normal cells, and that normal DNA hides the breaks.

The method aims to pinpoint breakpoints even when normal DNA is present in the sample. Finding exact break locations matters because they often reveal fused genes or lost control regions that push a cell toward cancer. A cleaner way to locate them could sharpen diagnosis and help match patients to treatments aimed at their tumor's specific errors.

Catalog record

CREATORYu-Tsueng Liu, Dennis A. Carson
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000380

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A Novel Approach for Determining Cancer Genomic Breakpoints in the Presence of Normal DNA Authors: Yu-Tsueng Liu, Dennis A. Carson Published: 2007, PLOS ONE DOI: 10.1371/journal.pone.0000380 ABSTRACT CDKN2A (encodes p16 INK4A and p14 ARF ) deletion, which results in both Rb and p53 inactivation, is the most common chromosomal anomaly in human cancers. To precisely map the deletion breakpoints is important to understanding the molecular mechanism of genomic rearrangement and may also be useful for clinical applications. However, current methods for determining the breakpoint are either of low resolution or require the isolation of relatively pure cancer cells, which can be difficult for clinical samples that are typically contaminated with various amounts of normal host cells. To overcome this hurdle, we have developed a novel approach, designated Primer Approximation Multiplex PCR (PAMP), for enriching breakpoint sequences followed by genomic tiling array hybridization to locate the breakpoints. In a series of proof-of-concept experiments, we were able to identify cancer-derived CDKN2A genomic breakpoints when more than 99.9% of wild type genome was present in a model system. This design can be scaled up with bioinformatics support and can be applied to validate other candidate cancer-associated loci that are revealed by other more systemic but lower throughput assays. INTRODUCTION Tumors evolve through the continuous accumulation and selection of randomly mutated genes. While sets of advantageous mutations are selected in tumors, neutral or even slightly detrimental mutations may also occur due to genomic instability and genetic drift. Recently, much effort has been expended to identify in primary human cancers point mutations in the exons of cancer-related genes. However, systemic mapping of genomic DNA rearrangements has lagged behind, due to technical difficulties in detecting smaller deletions, tumor heterogeneity, and the necessity to purify malignant from normal cells [1] . Historically, such work was done by time consuming and labor intensive genetics and molecular cloning on established cancer cell lines [2] , [3] , [4] . One of the most striking examples is the homozygous deletion of the CDKN2A ( INK4A/ARF ) tumor suppressor locus, which was discovered in this and other laboratories [3] , [4] , [5] , [6] , [7] , [8] . The CDKN2A deletions occur early during tumor development [9] , [10] , [11] . The p16 INK4a (one of the CDKN2A products [12] ) protein constrains cell cycle progression by the Rb pathway and may be responsible for the decline in the replicative potential of stem cells during aging [13] . The p14 ARF (the other alternative reading frame of CDKN2A [14] ) gene product regulates the expression of MDM2, the turnover of p53, and thereby controls the cellular response to stress (reviewed in [6] , [7] , [8] , [15] , [16] , [17] ). Because the Rb and p53 pathways are central to cancer gate-keeping and caretaking [18] , [19] , strong selection pressures exist for the disruption of the entire CDKN2A gene segment on both chromosomes. Few other deletions are as well characterized, although it is expected that more will be found when more data from array based comparative genomic hybridization (array-CGH) are reported and also through The Cancer Genome Atlas (TCGA) project [20] , [21] , [22] , [23] , [24] . It will be important to validate the relevance of those genomic rearrangements to cancer development since many of the genomic structural changes may be simply due to genome instability in cancer. Large scale studies with clinical samples will be the most reliable confirmation. While point mutations and very small insertions or deletions in genomic DNA can be detected by exon re-sequencing, it can be more difficult to detect gene dosage changes of larger genomic fragments, especially deletions [1] . Current established techniques for deletion mapping, including Southern blotting [25] , fluorescent in situ hybridization (FISH) [26] , quantitative PCR [26] , [27] , [28] , [29] , [30] , and array-CGH [31] rely on the absence of a detectable wild type signal [1] . This is problematic when a significant number of normal cells are present in a tumor sample. Array-CGH has the potential to analyze alterations of DNA copy number on a genome-wide scale with relatively high resolution, depending on whether BACs, PCR products or oligonucleotides are used for the array elements. However, these techniques often fail where there is a heterogeneous cell population or samples of poor quality [31] . FISH is less vulnerable to the presence of heterogeneous cell populations, but has relatively low resolution and is difficult to scale up. Except for FISH, the other techniques mentioned are not practical for mapping genomic translocations and inversions. End-sequencing profiling was developed to address this issue but the approach was costly and hard to scale up [32] . Therefore, there is a need to develop a scalable approach for detecting such genomic structural changes in solid tumors where heterogeneous cell populations are present. Here we report a novel approach, designated as Primer Approximation Multiplex PCR (PAMP), to enrich small amounts of deleted genomic DNA sequences in the presence of wild type DNA. The genomic locations of the enriched sequences are subsequently decoded by a genomic tiling array and confirmed by sequencing. RESULTS The CDKN2A is located on chromosome 9p21 ( Figure 1 ). It encodes two proteins in different reading frames: p16 INK4A and p14 ARF , which both have 3 exons and share exons 2 and 3. CDKN2B (p15 INK4B ) and MTAP (methylthioadenosine phosphorylase) (not shown) are centromeric and telomeric neighboring genes respectively [3] , [17] , [33] , [34] . BAC clone RP11-149I2 contains the whole CDKN2A genomic fragment and was used as template to generate probes (excluding repetitive regions) for printing on the minigenomic tiling array. The frequency of repetitive sequences predicted by RepeatMasker is shown at the bottom of the diagram. The genomic map covers about 55 kb around CDKN2A according to Ensemble [59] . CDKN2A /B is located at chromosome 9p21 and their RNA products are encoded by the reverse strand. CDKN2A encodes 2 proteins (p16 INK4A and p14 ARF ) that share the same exons 2 and 3. The first exons of INK4A and ARF are about 20 kb apart. CDKN2B encodes p15 INK4B that is homologous to p16 INK4A . In addition to transcripts, the map also shows repetitive sequences (Repeat) and available BAC clone (Human tilepath clones), RP11-149I2. PRIMER APPROXIMATION MULTIPLEX PCR (PAMP) It is difficult to detect a small fraction of deleted mutant genomic DNA in the presence of a vast excess of wild type DNA with array CGH or other popular molecular biology tools [26] , [27] , [35] . In typically contaminated tumor samples, genomic DNA is composed of various ratios of WT and CDKN2A deficient DNA. We aimed to take advantage of the fact that a shorter deleted genome sequence should be preferentially amplified compared to a much longer WT sequence using “approximated” flanking primers ( Figure 2A ) [36] . The efficiency of PCR amplification is inversely related to the distance of upstream and downstream primers. In this example, primers to amplify genomic sequences around the locus of interest (LOI) are divided into 20 groups: 10 each for forward (F1–F10) and reverse (R1-R10) groups (A). While all of the

Read the complete text